Nicholas Company Inc. boosted its stake in shares of Novanta Inc. (NASDAQ:NOVT – Free Report) by 65.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 35,369 shares of the technology company’s stock after buying an additional 13,944 shares during the quarter. Nicholas Company Inc. owned approximately 0.10% of Novanta worth $5,403,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Empowered Funds LLC bought a new stake in Novanta during the 4th quarter valued at about $26,000. SBI Securities Co. Ltd. bought a new stake in Novanta during the 4th quarter valued at about $97,000. Venturi Wealth Management LLC lifted its holdings in Novanta by 6,500.0% during the 4th quarter. Venturi Wealth Management LLC now owns 726 shares of the technology company’s stock valued at $111,000 after buying an additional 715 shares in the last quarter. KBC Group NV lifted its holdings in Novanta by 14.9% during the 3rd quarter. KBC Group NV now owns 1,059 shares of the technology company’s stock valued at $189,000 after buying an additional 137 shares in the last quarter. Finally, Associated Banc Corp bought a new stake in Novanta during the 3rd quarter valued at about $209,000. Institutional investors own 98.35% of the company’s stock.
Novanta Trading Up 1.2 %
NASDAQ NOVT opened at $136.07 on Friday. The company has a debt-to-equity ratio of 0.61, a quick ratio of 1.81 and a current ratio of 2.79. The company has a market capitalization of $4.89 billion, a price-to-earnings ratio of 81.48 and a beta of 1.34. The company’s 50-day simple moving average is $145.79 and its two-hundred day simple moving average is $161.42. Novanta Inc. has a one year low of $133.17 and a one year high of $187.12.
Analyst Upgrades and Downgrades
Separately, Robert W. Baird cut their target price on shares of Novanta from $169.00 to $160.00 and set a “neutral” rating on the stock in a research report on Monday, March 3rd.
Get Our Latest Stock Report on Novanta
Novanta Profile
Novanta, Inc engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures, and markets photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products.
See Also
- Five stocks we like better than Novanta
- 3 Small Caps With Big Return Potential
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- Top Biotech Stocks: Exploring Innovation Opportunities
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Want to see what other hedge funds are holding NOVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Novanta Inc. (NASDAQ:NOVT – Free Report).
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.